Greek Pharmaceutical Association warns of unsustainable clawback mechanisms

The Hellenic Association of Pharmaceutical Companies (SFEE) has informed Prime Minister Mitsotakis that current clawback-based expenditure controls are failing to ensure patient access to innovation. The industry argues that the existing fiscal model is unsustainable, signaling a potential breakdown in the supply chain or availability of new therapies in Greece.